SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

P. Sarafidis; C. J. Ferro; E. Morales; A. Ortiz; J. Malyszko; R. Hojs; K. Khazim; R. Ekart; J. Valdivielso; D. Fouque; G. M. London; Z. Massy; P. Ruggenenti; E. Porrini; A. Wiecek; C. Zoccali

doi:10.1093/ndt/gfz137

Journal Articles Nephrology Dialysis Transplantation Year : 2020

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

(1) , (2) , (3) , (4) , (5) , (6) , (7) , (6) , (8) , (9, 10, 11) , (12) , (13, 14) , (15) , (16, 17) , (18) , (19)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

P. Sarafidis

Function : Author

Aristotle University of Thessaloniki

C. J. Ferro

Function : Author

University Hospitals Birmingham [Birmingham, Royaume-Uni]

E. Morales

Function : Author

Hospital Universitario 12 de Octubre [Madrid]

A. Ortiz

Function : Author
PersonId : 755443
ORCID : 0000-0002-7212-2061

Universidad Autónoma de Madrid

J. Malyszko

Function : Author

Medical University of Warsaw - Poland

R. Hojs

Function : Author

University of Maribor

K. Khazim

Function : Author

Galilee Medical Center [Nahariya, Israel]

R. Ekart

Function : Author

University of Maribor

J. Valdivielso

Function : Author

Biomedical Research Institute of Lleida [Spain]

D. Fouque

Function : Author

Cardiovasculaire, métabolisme, diabétologie et nutrition

Centre Hospitalier Lyon Sud [CHU - HCL]

Université de Lyon

G. M. London

Function : Author

Centre Hospitalier Manhès [Fleury-Mérogis]

Z. Massy

Function : Author

Hôpital Ambroise Paré [AP-HP]

Université de Versailles Saint-Quentin-en-Yvelines

P. Ruggenenti

Function : Author

Azienda Ospedaliera Ospedale Papa Giovanni XXIII [Bergamo, Italy]

E. Porrini

Function : Author

Universidad de La Laguna [Tenerife - SP]

Hospital Universitario De Canarias

A. Wiecek

Function : Author

University of Silesia in Katowice

C. Zoccali

Function : Author

Ospedali riuniti di Reggio Calabria [Reggio Calabria, Italy]

Abstract

No abstract available

Domains

Life Sciences [q-bio]

Fichier principal

gfz137.pdf (49.24 Ko)

laboratoire CarMeN : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-03261177

Submitted on : Tuesday, June 15, 2021-2:57:16 PM

Last modification on : Tuesday, October 18, 2022-4:28:59 AM

Long-term archiving on: Thursday, September 16, 2021-6:50:52 PM

Dates and versions

inserm-03261177 , version 1 (15-06-2021)

Licence

Attribution - NonCommercial - CC BY 4.0

Identifiers

HAL Id : inserm-03261177 , version 1
DOI : 10.1093/ndt/gfz137
PUBMED : 31397476
WOS : 000607839600028

Cite

P. Sarafidis, C. J. Ferro, E. Morales, A. Ortiz, J. Malyszko, et al.. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. Nephrology Dialysis Transplantation, 2020, 35 (10), pp.1825. ⟨10.1093/ndt/gfz137⟩. ⟨inserm-03261177⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM HCL UNIV-LYON1 INSA-LYON CHLS UVSQ UNIV-PARIS-SACLAY CARMEN INSA-GROUPE UDL INRAE

19 View

331 Download

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

Abstract

Domains

Dates and versions

Licence

Identifiers

Cite

Export

Collections

Altmetric

Share